Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

31/gen/2019 13:36:45 sai krishna Contatta l'autore

Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market is Expected to Reach around US$ XX Bn by 2025, Due to Growing Healthcare Expenditure

 

The Attention Deficit Hyperactivity Treatment Market is anticipated to reach about US$ XX Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to increasing healthcare expenditure & rising prevalence of ADHD.

 

Precision Business Insights (PBI) in its report titled “Attention Deficit Hypersensitive Treatment Disorder Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

The attention deficit hyperactivity treatment market size was accounted for US$ XX Bn in 2018 and anticipated to account for US$ XX Bn by 2025. Increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs and mounting occurrence of ADHD. Key trends and developments of this market includes progressing drugs under pipeline, high demand for dual therapy and rising preference for EEG biofeedback therapy. However, there are some factors which can hinder growth of the market including medical complications of existing drug therapies, high domination of generic pharmaceutical market and strict government protocols.

 

Free sample of this report is available upon request @

 

https://www.precisionbusinessinsights.com/market-reports/global-attention-deficit-hyperactivity-treatment-disorder-adhd-market/#ulp-h4n2eZVGqb32xpPc

 

Attention deficit hyperactivity treatment market segmented on the basis of medication type, age group and distribution channel.

 

Adult Age Group Expected to Dominate the Market

 

On the basis of age group, the market has been segmented into pediatric and adolescent, and adults. The adults age group segment accounted for highest revenue share of XX% in 2015, and is expected to retain its dominance throughout the forecast period.

 

Retail Pharmacies Will Dominate the Revenue Share.

 

On the basis of distribution channel, the market has been segmented into Specialty Clinics, Hospital Pharmacies, Retail Pharmacies, and e-Commerce. Retail pharmacies is the most preferred medium of drug distribution, and this segment accounted for highest revenue share of XX% in 2015, and is expected to retain its dominance throughout the forecast period.

 

North America, Accounts for Major Revenue Share for Market

 

Precision Business Insights (PBI) attention deficit hyperactivity treatment market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America is expected to dominate the global ADHD therapeutics market owing to the presence of clinical ongoing trials, quick FDA approval of therapeutics, existence of innovative brain monitoring technologies coupled with insurance policies, and government support for technological advancements. The market in Asia Pacific is expected to rise owing to increasing health awareness involving public organizations and manufacturing effective therapeutics for ADHD treatment. Europe and Asia Pacific are estimated to be the fastest growing emerging markets over the forecast period. Currently, stimulants drugs are a major revenue contributor in most regions. Rising prevalence of ADHD across the globe owing to low threshold of diagnostic criteria is expected to fuel revenue growth of global ADHD therapeutics market over the forecast period.

 

Free TOC of this report is available upon request @

 

https://www.precisionbusinessinsights.com/market-reports/global-attention-deficit-hyperactivity-treatment-disorder-adhd-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

U.S.FDA Approvals Play Vital Role in Attention Deficit Hypersensitivity Treatment Market

                                                                

Some of the key players are actively promoting their products by adopting various market strategy which sheers their footprint in the global market. In June 2017, Shire Plc received U.S. FDA approval for a long-acting attention-deficit drug Adderall XR aimed at adolescents and adults

Key players covered in the global ADHD therapeutics drug market report include Eli Lilly and Company, Novartis AG, Shire PLC, Pfizer, Inc., GlaxoSmithKline PLC, Mallinckrodt Pharmaceuticals, Hisamitsu Pharmaceutical Co., Inc., Impax Laboratories, Inc., Johnson & Johnson, UCB S.A., and Purdue Parma L.P. among others.

 

Detailed Segmentation

 

By Medication Type

 

o   Stimulants

·         Amphetamines

·         Methylphenidate

·         Dextroamphetamine

·         Dexmethylphenidate

o   Non-Stimulants

·         Atomoxetine

·         Bupropion

·         Guanfacine

 

By Age Group Type

 

o   Paediatric

o   Adolescent

o   Adults

 

By Distribution Channel Type

 

o   Hospital pharmacies

o   Specialty clinics

o   Retail pharmacies

o   Online pharmacies

 

Geography

 

o   North America

§  U.S.

§  Canada

o   Europe

§  Germany

§  UK

§  France

§  Russia

§  Spain

§  Italy

§  Rest of Europe

o   Asia-Pacific

§  China

§  Japan

§  India

§  ASEAN

§  Rest of Asia Pacific

o   Latin America

§  Brazil

§  Mexico

§  Argentina

§  Chile

§  Rest of Latin America

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  Rest of MEA

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-attention-deficit-hyperactivity-treatment-disorder-adhd-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading 
market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: 
sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ 
www.precisionbusinessinsights.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl